Mirtazapine Impurity B |
|
| Synonyms: Mirtazapine N-Oxide; 1,2,3,4,10,14b-Hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-Oxide. (14bRS)-2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1- a]pyrido[2,3-c][2]benzazepine 2-oxide; Mirtazapine EP Impurity A; USP Mirtazapine Related Compound B; | |
| Cat. No.: M65006 | CAS No.: 155172-12-6 |
| MDL.: | Formula: C17H19N3O |
| F.W.281.35 | Purity: 99% |
| Storage: Hygroscopic, Store under Inert atmosphere -20°C Freezer | |
|   | |
| Catalog Number: | M65006 | CAS No.: | 155172-12-6 | |
| MDL: | Formula: | C17H19N3O | ||
| F.W.: | 281.35 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | Pale Yellow Solid | M.P.: | 164-166°C | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Chloroform, Methanol | Stability: | ||
| Storage: | Hygroscopic, Store under Inert atmosphere -20°C Freezer | Category: | Reference Standard | |
| Reference: | Kobayashi, K., et al.: J. Pharmacol. Exp. Ther., 280, 927 (1997), von Moltke, L., et al.: J. Pharm. Pharmacol., 50, 997 (1998), Moore, K., et al.: J. Anal. Toxicol., 23, 541 (1999), Stormer, E., et al.: Drug Metab. Dispos., 28, 1168 (2000), | |||
| Application: | A metabolite of Mirtazapine. | |||
| Category: | Metabolites & Impurities, Pharmaceuticals, Intermediates & Fine Chemicals, | |||








